Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.
Lee las últimas noticias de Breakthrough T1D.
Breakthrough T1D’s first-ever Clinical & Research Congress (CRC 2026), focused entirely on type 1 diabetes (T1D), has come to a close! Check out all our coverage below from the exciting weekend in Philadelphia, PA, where researchers, clinicians, industry leaders, healthcare professionals (HCPs), and the T1D community united to share updates across our entire mission. Updates […]
It’s a rainy day in Philadelphia, but the mood at CRC 2026 could not be sunnier! The attendees were positively buzzing (seriously) with how timely and impactful this meeting is. It’s the right time for a meeting focused exclusively on type 1 diabetes (T1D), and the good news is we won’t have to wait years […]
We are two days into the first ever Breakthrough T1D Clinical & Research Congress! Day 1 was full of optimism and excitement about the meeting—it’s really ALL type 1 diabetes (T1D), which is unique—and the future of treatments and therapies for this community. Breakthrough T1D’s Clinical & Research Congress The inaugural Breakthrough T1D Clinical & […]
Hello from Philadelphia, PA! We could not be more thrilled that, after years and years, we have finally kicked off our inaugural Breakthrough T1D Clinical & Research Congress (CRC). This groundbreaking event is focused entirely on type 1 diabetes (T1D), and it’s happening right now! Breakthrough T1D’s Clinical & Research Congress The inaugural Breakthrough T1D […]
Cold and flu season is right around the corner! Being sick is never fun, but for people living with type 1 diabetes (T1D), it poses extra concerns. When a person gets sick, their body is under stress. To combat that stress, the body naturally releases hormones that help fight disease. Those hormones, however, can cause […]
Heart and kidney complications remain a major concern for people living with type 1 diabetes (T1D). While there are some therapies available to reduce the risk of these complications, the T1D community urgently needs more options. SGLT inhibitors (SGLTi), which have proven effective in people with type 2 diabetes (T2D) and people without diabetes, are […]
¡Vaya! No hemos podido localizar tu formulario.
